Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment

The absence of potent therapeutic option accounts for the dismal prognosis of advanced hepatocellular carcinoma (HCC) with high mortality and recurrence rate. For a decade, sorafenib is the only approved systemic drug in the first-line setting and warrants as the standard-of-care for HCC in the adva...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Gastroenterol Hepatol
Main Authors: Siu, Elaine Hon-Lam, Chan, Anthony Wing-Hung, Chong, Charing Ching-Ning, Chan, Stephen Lam, Lo, Kwok-Wai, Cheung, Siu Tim
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2018
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286919/
https://ncbi.nlm.nih.gov/pubmed/30603725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.10.16
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker